Azmi Nabulsi - 18 Jan 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Larry Miller, Attorney-in-Fact for Azmi Nabulsi
Issuer symbol
PHAT
Transactions as of
18 Jan 2024
Transactions value $
$0
Form type
4
Filing time
22 Jan 2024, 20:21:44 UTC
Previous filing
03 Nov 2023
Next filing
31 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy) Award $0 +130K $0.00 130K 18 Jan 2024 Common Stock 130K $7.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the shares of common stock on January 18, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.

Remarks:

Exhibit 24 - Power of Attorney